Stockreport

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis [Yahoo! Finance]

Chemomab Therapeutics Ltd. - American Depositary Shares  (CMMB) 
PDF —New Clinical Data Provides Insights on Nebokitug's Direct Macrophage-Mediated Mechanisms that Are Key to PSC Disease Progression— — All Three Presentations Have Been [Read more]